case_images: PMC9744936_01
case_images: Effect of various treatments on the hemoglobin and reticulocyte count for patient 1.
case_images: fimmu-13-1055473-g001.jpg
case_images: PMC9744936_01_fimmu-13-1055473-g001.jpg
case_images: f1
case_images: Her hemoglobin remains stable (7.2 - 9.5g/dL) since ( Figure 1 ).
case_images: PMC9744936_02
case_images: PMC9744936_03
case_images: Donor specific antibody response to daratumumab.
case_images: fimmu-13-1055473-g002.jpg
case_images: PMC9744936_03_fimmu-13-1055473-g002.jpg
case_images: f2
case_images: Due to failure of IST, work up for haploidentical HSCT was done which showed presence of donor specific antibodies (DSA), for which she received weekly daratumumab infusions (16 mg/kg/dose) for 5 weeks with a significant reduction in DSA and was able to receive a HSCT from a previously unsuitable haplo-identical donor ( Figure 2 ).